Actively Recruiting
Effect of ERAS Nursing on Patient Outcomes After Minimally Invasive Lung Cancer Surgery
Led by The Second Hospital of Shandong University · Updated on 2022-11-16
600
Participants Needed
1
Research Sites
221 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the impact of the Enhanced Recovery After Surgery ERAS nursing program on patients undergoing minimally invasive lung cancer surgery. The study compares patient-reported outcomes, hospital stay length, complications, and readmission rates between those receiving ERAS nursing care and those receiving routine nursing care. This is an interventional, randomized trial led by The Second Hospital of Shandong University. Participants are assigned to either the ERAS nursing group or the non-ERAS nursing group. The ERAS nursing program includes patient education before surgery, management of fluids and anesthesia during surgery, encouragement of early movement, careful fluid control, and early feeding after surgery. The non-ERAS group receives standard routine nursing care without the ERAS protocol. During the study, patients will report their outcomes at baseline, daily after surgery, and weekly for up to four weeks after discharge. Researchers will also track hospital length of stay, postoperative cardiopulmonary complications, and readmission rates from admission through one month after discharge. The total participation duration varies according to these follow-up points, allowing thorough monitoring of recovery and complications.
CONDITIONS
Brief Title
Self-reported Outcomes of Patients in ERAS Nursing
Research Team
Y
ying liu
H
Hongju Wang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
